Global Monoclonal Antibodies Market was Valued at US$ 208.32 Bn in 2022 and is Expected to hit a Revenue of US$ 647 Bn at CAGR of 12% Between Forecast Period of 2022-32 | Future Market Insights, Inc.

Increasing Medical Tourism in Asia Pacific is Spurring Demand for Monoclonal Antibodies. The U.S. expected to account for over 46.2% of the North American Monoclonal Antibodies Market during the forecast period. Novartis AG; Pfizer Inc; GlaxoSmithKline plc; Amgen Inc.; Merck & Co., Inc. are some prominent Monoclonal Antibodies manufacturers

NEWARK, Del., Nov. 14, 2022 /PRNewswire/ -- The global demand for monoclonal antibodies market is projected to increase at a CAGR of 12% during the forecast period between 2022 and 2032, reaching a total of US$ 647.01 Billion in 2032, according to a report from Future Market Insights (FMI). From 2017 to 2021, sales witnessed significant growth, registering a CAGR of 6.1%.

Human mAbs offer efficient modulation in effector functions and are less immunogenic as compared to chimeric or humanized mAbs. Such antibodies can be produced through the use of phage display and hybridoma technologies in transgenic mice. As a result, with recent technological progress in genetic engineering, the production of fully human mAbs is anticipated to gain traction in the near future. 

Request for In-depth Report Sample@
https://www.futuremarketinsights.com/reports/sample/rep-gb-15756

North America recorded the largest market share of 46.2% in 2021 due to the presence of a highly developed healthcare infrastructure, high patient awareness, and growth in cancer research prospects, among other factors. Moreover, increasing government expenditure for cancer research and the presence of key players such as Pfizer Inc., Amgen, Inc., and Merck & Co., among others, are expected to boost the market growth. 

Rising healthcare expenditure across the world, increasing patient awareness levels, and availability of advanced hospital infrastructure in developed countries are factors expected to result in the dominance of the segment during the forecast period.

 Key Takeaways from the Market Study 

• In 2022, the global monoclonal antibodies market size was valued at USD 186 billion in 2021.
• The market is projected to increase at a CAGR of 12% during the forecast period between 2022 and 2032, reaching a total of US$ 647.01 Billion in 2032
• The human source type held the largest share and accounted for 54.07% of the market value in 2021. 
• The North American market for monoclonal antibodies expanded with a market share of 46.2% in 2022.
• Asia Pacific is projected to exhibit the fastest growth rate in the forecast period.

"Applications of mAbs for the treatment of autoimmune diseases are projected to grow at a lucrative rate due to the increasing prevalence of autoimmune conditions such as rheumatoid arthritis." comments a Future Market Insights analyst.

Ask to Analyst, About this Report@
https://www.futuremarketinsights.com/ask-question/rep-gb-15756

Competitive Landscape 

The market is expected to become more competitive in the near future, as many companies focus their efforts on research and the creation of innovative diagnostic techniques through product line expansions, acquisitions, and mergers. Key players in the Monoclonal Antibodies market areNovartis AG; Pfizer Inc; GlaxoSmithKline plc; Amgen Inc.; Merck & Co., Inc.; Daiichi Sankyo Company, Limited; Abbott Laboratories; AstraZeneca plc; Eli Lilly And Company; Johnson & Johnson Services, Inc. and many more. 

• In November 2021, Bristol-Myers Squibb Company received the U.S. Food and Drug Administration approval for Opdivo (nivolumab) plus Yervoy (ipilimumab) combined with limited chemotherapy as first-line treatment of metastatic or recurrent non-small cell lung cancer. Patients with squamous or non-squamous illness, independent of PD-L1 expression, are eligible for the treatment. 1 The FDA's Real-Time Oncology Examine (RTOR) pilot programme was used to review this application, which aims to ensure that safe and effective medicines are offered to patients as soon as feasible.
• In March 2022, Sanofi S.A. and Blackstone Life Sciences entered a collaboration for accelerating the development of a subcutaneous formulation of Sarclisa mAb for the treatment of patients with multiple myeloma.

More Valuable Insights 

Future Market Insights, in its new offering, presents an unbiased analysis of the global monoclonal antibodies market, presenting historical analysis from 2016 to 2021 and forecast statistics for the period of 2022-2032.

The study reveals essential insights on the basis of test type (tumor biomarkers tests, imaging, biopsy, liquid biopsy, immunohistochemistry, in situ hybridization), by indication (breast cancer, lung cancer, colorectal cancer, melanoma, blood cancer, prostate cancer, ovarian cancer, stomach cancer, liver cancer and others) and by end-user (hospital associated labs, independent, diagnostic laboratories, diagnostic imaging centers, cancer research institutes and others) and regions (North America, Latin America, Europe, Asia Pacific, and Middle East & Africa).

Click on the Below Link to Buy this Report@
https://www.futuremarketinsights.com/checkout/15756

Key Segments Profiled in the Monoclonal Antibodies Market Industry Survey

Monoclonal Antibodies Market by Production Type:

• In Vivo
• In Vitro

Monoclonal Antibodies Market by Source Type:

• Murine
• Chimeric
• Humanized
• Human

Monoclonal Antibodies Market by End User:

• Hospitals
• Specialty Centers
• Others

Monoclonal Antibodies Market by Application:

• Oncology
• Autoimmune Diseases
• Infectious Diseases
• Neurological Diseases
• Others

Monoclonal Antibodies Market by Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa (MEA)

About the Healthcare at Future Market Insights 

The healthcare domain at Future Market Insights offers expert analysis, time-efficient research, and strategic recommendations with an objective to provide authentic insights and accurate results to help clients worldwide. With a repertoire of over 100+ reports and 1 million+ data points, the team has been analyzing the industry lucidly in 50+ countries for over a decade. The team provides a brief analysis of key trends including competitive landscape, profit margin, and research development efforts.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

Report Preview@ https://www.futuremarketinsights.com/reports/monoclonal-antibodies-market

Have a Look at Related Research Reports of Healthcare

Benign Prostatic Hyperplasia (BPH) Prostate Treatment Market Forecast: Standing at a net worth of US$ 30.04 Bn in 2022, the global benign prostatic hyperplasia (BPH) prostate treatment market is anticipated to attain a valuation of US$ 39.5 Bn by the end of 2028

Hematology Diagnostics Market Size: Standing at a valuation of US$ 725 Mn in 2022, the global hematology diagnostics market is projected to reach US$ 1.2 Bn by the end of 2031

Loop-mediated Isothermal Amplification (LAMP) Market Outlook: Loop-mediated isothermal amplification (LAMP) market revenue totaled US$ 95.1 Mn in 2021. The global market is expected to reach US$ 120.4 Mn by 2028, rising at a CAGR of 3.4%

Endoscopic Ultrasound Needles Market Sales: Progressing at a CAGR of 4.4%, the global endoscopic ultrasound needles market is projected to increase from a valuation of US$ 180.2 Mn in 2022 to US$ 223.5 Mn by the end of 2027

Gastroesophageal Reflux Disease (GERD) Devices Market Share: Global sales of gastroesophageal reflux disease (GERD) devices were valued at around US$ 1.12 Bn at the end of 2021

Electronic Stethoscope Market Value: Global Electronic Stethoscope Market was valued at US$ 170.9 Mn in 2021 and the sales are expected to surpass US$ 259 Mn, increasing by 2.2x between 2022 and 2029

Disposable Spinal Instruments Market Type: The global Disposable Spinal Instruments Market is estimated to be worth around US$ 59.7 Mn in 2022

Pharmaceutical Intermediates Market Analysis: Pharmaceutical intermediates are used as raw materials during the manufacture of bulk drugs

Vision Screeners Market Growth: The global Vision Screeners Market is expected to grow at a CAGR of 5.9% during the forecast period 2022-2029

Viscosupplementation Market Trends: Worldwide viscosupplementation equipment sales are set to be valued at US$ 1.98 Bn in 2022

About Future Market Insights, Inc.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Contact:
Future Market Insights Inc.  
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA  
T: +1-845-579-5705  
For Sales Enquiries: [email protected]

Logo: https://mma.prnewswire.com/media/1197648/FMI_Logo.jpg 

SOURCE Future Market Insights